Polymorphisms of HLA-A and HLA-B genes in genetic susceptibility to esophageal carcinoma in Chaoshan Han Chinese

Diseases of the Esophagus

Volumn 23, Issue 1, 2010, Pages 46-52

  Hu, Sheng Ping ^a   Zhou, Guang Biao ^a   Luan, Jian An ^b   Chen, Yu Ping ^a   Xiao, Da Wei ^a   Deng, Yu Ju ^a   Huang, Li Qun ^a   Cai, Ke Li ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

Author keywords

Chaoshan han Chinese; Esophageal carcinoma; Genetic polymorphism; HLA A and B; Nasopharyngeal carcinoma

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOMINANT INHERITANCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECESSIVE INHERITANCE;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; ETHNIC GROUPS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; POLYMORPHISM, GENETIC;

EID: 77953192482     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.00965.x     Document Type: Article

References (46)

1. Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Yang L, Parkin D M, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14: 243-50.
3. Su M, LiuM, Tian D P et al. Temporal trends of esophageal cancer during 1995-2004 in Nanao Island, an extremely highrisk area in China. Eur J Epidemiol 2007; 22: 43-8.
4. Chang-Claude J, Becher H, Blettner M, Qiu S, Yang G, Wahrendorf J. Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol 1997; 26: 1159-65.
5. Su M, Tian D P, Li X Y, Sun J K, Li Y F, Yang H L. Four case reports of families with esophageal cancer in a high-risk region on the Guangdong Chaoshan coast of China. Dis Esophagus 2002; 15: 257-61.
6. Hemminki K, Jiang Y. Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 2002; 98: 106-9.
7. Garavello W, Negri E, Talamini R et al. Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomarkers Prev 2005; 14: 1390-3.
8. Akbari M R, Malekzadeh R, Nasrollahzadeh D et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer 2006; 119: 1047-51.
9. Carter C L, Hu N,WuM, Lin P Z, Murigande C, Bonney G E. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst 1992; 84: 771-6.
10. Zhang W H, Bailey-Wilson J E, Li W D et al. Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet 2000; 67: 110-9.
11. Hu N, Wang C, Hu Y et al. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array. BMC Genomics 2006; 7: 299-314.
12. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and esophageal cancer risk. Int J Cancer 2007; 121: 1643-58.
13. The MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401: 921-3.
14. Horton R,Wilming L, Rand V et al. Gene map of the extended human MHC. Nat Rev Genet 2004; 5: 889-99.
15. Shiina T, Inoko H, Kulski J K. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64: 631-49.
16. Ghodke Y, Joshi K, Chopra A, Patwardhan B. HLA and disease. Eur J Epidemiol 2005; 20: 475-88.
17. Leichman L, Israel V. Neoplasms of the esophagus. In: Calabresi P, Schein P S, Canellos G P, Glick J H, Macdonald J S, Von Hoff D D (eds). Medical Oncology. New York: McGraw-Hill, 1983; 649-70.
18. Lin J, Deng C S, Sun J et al. HLA-DRB1 allele polymorphisms in genetic susceptibility to esophageal carcinoma. World J Gastroenterol 2003; 9: 412-6.
19. Eivazi-Ziaei J, Dastgiri S, Majidi J, Vaez J, Asvadi I, Mahmoudpour A. Human leukocyte antigen and esophageal cancer in the northwestern region of Iran. Dis Esophagus 2006; 19: 238-40.
20. Hu S P, Day N E, Li D R et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005; 92: 967-70.
21. Lu C C, Chen J C, Jin Y T, Yang H B, Chan S H, Tsai S T. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer 2003; 103: 745-51.
22. Breslow N E, Day N E. Statistical methods in cancer research, vol I - the analysis of case-control studies. IARC Sci Publ 1980; 32: 13-338.
23. Hu S P, Luan J A, Li B et al. Genetic link between Chaoshan and other Chinese Han populations: evidence from HLA-A and HLA-B allele frequency distribution. Am J Phys Anthropol 2007; 132: 140-50.
24. Lancaster A, Nelson M P, Meyer D, Thomson G, Single R M. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 2003; 8: 514-25.
25. Perneger T V. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-8.
26. Shaw C K, Chen L L, Lee A, Lee T D. Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens 1999; 53: 51-64.
27. Carrington M, Nelson G W, Martin M P et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283: 1748-52.
28. Tang J, Costello C, Keet I P et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1999; 15: 317-24.
29. Jeffery K J, Siddiqui A A, BunceMet al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000; 165: 7278-84.
30. Seppänen M, Lokki M L, Timonen T et al. Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections. Clin Infect Dis 2001; 33: 1604-7.
31. Gow P, Hathaway M, Gunson B, Heward J, Mutimer D. Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3. J Gastroenterol Hepatol 2005; 20: 555-61.
32. Dubey D P, Yunis I, Leslie C A,Mehta C, Yunis E J. Homozygosity in the major histocompatibility complex region influences natural killer cell activity in man. Eur J Immunol 1987; 17: 61-6.
33. Husain Z, Levitan E, Larsen C E et al. HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells. J Clin Immunol 2002; 22: 28-36.
34. Zinkernagel R M, Doherty P C. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 1974; 251: 547-8.
35. Prugnolle F, Manica A, Charpentier M, Guégan J F, Guernier V, Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 2005; 15: 1022-7.
36. Syrjänen K J. HPV infections and oesophageal cancer. J Clin Pathol 2002; 55: 721-8.
37. Shen Z Y, Hu S P, Lu L C et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68: 412-6.
38. Liu D W, Yang Y C, Lin H F et al. Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients. J Virol 2007; 81: 2869-79.
39. de Campos-Lima P O, Gavioli R, Zhang Q J et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993; 260: 98-100.
40. Gavioli R, Zhang Q J, Masucci M G. HLA-A11-mediated protection from NK cell-mediated lysis: role of HLA-A11-presented peptides. Hum Immunol 1996; 49: 1-12.
41. Simons M J, Chan S H, Wee G B et al. Nasopharyngeal carcinoma and histocompatibility antigens. IARC Sci Publ 1978; 20: 271-82.
42. Hildesheim A, Apple R J, Chen C J et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002; 94: 1780-9.
43. +-thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 2005; 106: 368-71.
44. Welcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661-78.
45. Chan S H, Day N E, Kunaratnam N, Chia K B, Simons M J. HLA and nasopharyngeal carcinoma in Chinese - a further study. Int J Cancer 1983; 32: 171-6.
46. Simons M J, Wee G B, Goh E H et al. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2). J Natl Cancer Inst 1976; 57: 977-80.